About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Texas | 864 Studies

Clinical Trials Prostate CancerTexas

Prostate Cancer Clinical Trials in Texas

Find 864 clinical trials for prostate cancer near Texas. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 621-640 of 864 trials

TerminatedA Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid TumorsThis study is an open-label, multi-center, dose-escalation, dose expansion study in adult subjects with advanced solid tumors.NCT05084859·Tucson, Arizona and 19 others CompletedA Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation TherapyThe goal of the first part of this clinical research study is to learn how to deliver more accurate radiation treatment of tumors in the spine.NCT01624220·Houston, Texas

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedProstate Conformal CryotherapyThe goal of this clinical research study is to learn if using cryotherapy to treat only the part of the prostate that contains cancer is an effective treatment for prostate cancer.NCT00877682·Houston, Texas

TerminatedExpanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)The SPERA trial is designed to 1. provide satraplatin to physicians with patients who have hormone refractory prostate cancer (HRPC) which has progressed following unlimited…NCT00450970·Birmingham, Alabama and 120 others

Active not recruitingA Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate CancerProstate cancer has the second highest incidence rate and is the fifth leading cause of cancer-related deaths among men worldwide.NCT06318273·Duarte, California and 25 others

TerminatedDose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid TumorsThis is a Phase 1, multicenter, open-label, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, and preliminary evidence of antitumor…NCT04931823·Los Angeles, California and 7 others

CompletedStudy of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate CancerThe purpose of this study is to find the recommended doses of dasatinib and docetaxel given in combination to men with metastatic hormone refractory prostate cancer and to assess…NCT00439270·Chicago, Illinois and 4 others

TerminatedSafety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPCA phase 1 study evaluating the safety, tolerability, pharmacokinetics, and efficacy of prostate specific membrane antigen half-life extended bispecific T-cell engager acapatamab…NCT03792841·Campbell, California and 29 others

CompletedCHESS: Human and Computer Mentors for Prostate Cancer PatientsThe aims include: 1. To measure the effect of the three study conditions on Quality of Life (QOL).NCT00516256·Hartford, Connecticut and 2 others

CompletedTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerPhase I trial to study the effectiveness of trastuzumab plus R115777 in treating patients who have advanced or metastatic cancer.NCT00005842·Fort Sam Houston, Texas and 1 other

CompletedPS-341 Followed by Removal of Prostate for Those With Prostate CancerFollowing pretreatment evaluation, patients receive PS-341 by intravenous push weekly for 4 consecutive weeks followed by a 24-72 hour rest period.NCT00425503·Houston, Texas

RecruitingTogether Stronger: A Family-centered Lifestyle Intervention for Black Prostate Cancer Survivors and Their CaregiversTo establish the efficacy of the family-centered intervention in improving healthy lifestyle behaviors (MVPA and overall diet quality), as well as physical functioning, QoL, and…NCT07164456·Houston, Texas

RecruitingInternational Registry for Men With Advanced Prostate Cancer (IRONMAN)Our intent is to establish the International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRONMAN) as a prospective, international cohort of minimum 5,000…NCT03151629·Birmingham, Alabama and 120 others

CompletedHSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate CancerThe purpose of this study is to conduct a Phase I - II clinical trial to extend preclinical studies involving in situ HSV-tk + Valacyclovir gene therapy in combination with…NCT01913106·Houston, Texas

RecruitingWater Vapor Ablation for Prostate Cancer: Long-Term RegistryThe purpose of the registry is to evaluate real-world safety, efficacy, and patient reported outcomes among participants receiving Vanquish Water Vapor Ablation System therapy…NCT07455058·Bossier City, Louisiana and 3 others

CompletedSurgery in Treating Patients With Prostate CancerRATIONALE: Prostatectomy may be an effective treatment for prostate cancer that has not responded to radiation therapy.NCT00002938·Anniston, Alabama and 60 others

Completed3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate CancerThe investigators will propose a novel method to improve prostate cancer screening with PSA, using a 3-month treatment with finasteride, a drug used to treat Benign Prostatic…NCT01296672·San Antonio, Texas

Active not recruitingNational Cancer Institute "Cancer Moonshot Biobank"This trial collects multiple tissue and blood samples, along with medical information, from cancer patients. The "Cancer Moonshot Biobank" is a longitudinal study.NCT04314401·Daphne, Alabama and 149 others

CompletedA Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate CancerEnthuse M1C is a large phase III clinical trial studying the safety and efficacy of ZD4054 (Zibotentan) in combination with docetaxel (Taxotere) in patients with metastatic…NCT00617669·Greenbrae, California and 146 others

CompletedA Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer PatientsThe purpose of this study was to explore the safety and tolerability of enzalutamide in combination with abiraterone acetate plus prednisone.NCT01650194·Houston, Texas

PreviousPage 32 of 44Next

Other Conditions in Texas

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma